TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Medtronic
• Grant Support/Research Contract (Institutional) - Abbott Vascular; Boston Scientific Corporation; W.L. Gore & Associates; Edwards Lifesciences; Jena